Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
LOPERAMID Mepha lingual Schmelztabl 2 mg 20 Stk
Drug
Loperamid-Mepha lingual, Schmelztabletten
Symptomatische Behandlung akute und chronischer Diarrhö verschiedenster Genese, ein-schliesslich Reisediarrhö, Diarrhö nach Ileostomie oder Resektion des Ileums, Diarrhö nach Bestrahlung, Stuhlinkontinenz.
04.09.0. – antidiarrhoeals
HAM – Human medicine
SCHM – Orodispersible tablet
S – synthetic products for human use
D – Dispensed following expert advice (D)
Z – approved
3/17/2022
3/16/2027
Dosage strength
Loperamid-Mepha lingual 2 mg, Schmelztabletten
Symptomatische Behandlung akute und chronischer Diarrhö verschiedenster Genese, ein-schliesslich Reisediarrhö, Diarrhö nach Ileostomie oder Resektion des Ileums, Diarrhö nach Bestrahlung, Stuhlinkontinenz.
01
Z – approved
Package
7680683250010
No information made available
A/R – Authorised / referenced
20 tablet(s)
001
Z – approved
Declaration
Component
2.00 mg loperamidi hydrochloridum
carmellosum natricum conexum
0.45 mg natrium
5.00 mg aspartamum
aromatica
13-18 µg saccharum
magnesii stearas
mannitolum
0.45 mg natrium
5.00 mg aspartamum
aromatica
13-18 µg saccharum
magnesii stearas
mannitolum
Authorisation holder
7601001396685
Mepha Pharma AG
Kirschgartenstrasse 14
4051 Basel (BS)
Kirschgartenstrasse 14
4051 Basel (BS)
Date of revision of the text
6/1/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.